Use of Cyproterone Acetate in Prostate Cancer

This publication has 40 references indexed in Scilit:

• Serum Prolactin Assays Have No Prognostic Value in Treatment of Prostatic Cancer by Orchidectomy or Estrogens
  Urologia Internationalis, 1987
• Androgen action blockade does not result in reduction in size but changes histology of the normal human prostate
  The Prostate, 1987
• Effect of cyproterone acetate in comparison to flutamide and megestrol acetate on the ventral prostate, seminal vesicle, and adrenal glands of adult male rats
  The Prostate, 1987
• Intratissular androgens in benign prostatic hyperplasia and prostatic cancer
  Journal of Steroid Biochemistry, 1986
• Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate and megestrol acetate
  Molecular and Cellular Endocrinology, 1985
• COMBINED TREATMENT WITH BUSEREUN AND CYPROTERONE ACETATE IN METASTATIC PROSTATIC CARCINOMA
  The Lancet, 1985
• The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer
  The Prostate, 1984
• Mechanisms of action of androgens and antiandrogens: Effects of antiandrogens on translocation of cytoplasmic androgen receptor and nuclear abundance of dihydrotestosterone
  The Prostate, 1982
• Orchiectomy Combined with Cyproterone Acetate or Prednisone in the Treatment of Advanced Prostatic Carcinoma
  Scandinavian Journal of Urology and Nephrology, 1982
• Treatment of Prostatic Carcinoma with Cyproterone Acetate
  Scandinavian Journal of Urology and Nephrology, 1978